Clinical trials
Terminated Carcinoma, Renal Cell trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Hoffmann-La Roche | 2 |
| AbbVie | 1 |
| Actym Therapeutics, Inc. | 1 |
| Apollomics (Australia) Pty. Ltd. | 1 |
| CRISPR Therapeutics AG | 1 |
| Ludwig Institute for Cancer Research | 1 |
| MacroGenics | 1 |
| Nektar Therapeutics | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 14 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Ovarian Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Melanoma | 3 |
| Bile Duct Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Colorectal Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.